
First Tracks Biotherapeutics Inc
TRAXNASDAQHealthcareBiotechnology
أحدث البيانات المتاحة
31.85 US$
−0.16 US$ · -0.50%
TRAX نظرة عامة على الشركة
ملف الشركة
First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.


















